ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

HR+/HER2- Breast Cancer · HR+, HER2-, Advanced Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Avenzo Therapeutics Recruiting Site, Los Angeles, California, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Los Angeles, California, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, New Haven, Connecticut, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Orlando, Florida, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Sarasota, Florida, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Boston, Massachusetts, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, New York, New York, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Cleveland, Ohio, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Columbus, Ohio, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Nashville, Tennessee, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Fort Worth, Texas, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Houston, Texas, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, San Antonio, Texas, United States
Contact: Study coordinator (Avenzo Therapeutics)
Avenzo Therapeutics Recruiting Site, Fairfax, Virginia, United States
Contact: Study coordinator (Avenzo Therapeutics)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Duarte, United States · Fullerton, United States

Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer

Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Shijiazhuang, China

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation · HER2- Negative Breast Cancer · Hormone Receptor Positive Tumor

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Beverly Hills, United States